Skip to main content

Peer Review reports

From: Rare mutation-dominant compound EGFR-positive NSCLC is associated with enriched kinase domain-resided variants of uncertain significance and poor clinical outcomes

Original Submission
14 Jun 2022 Submitted Original manuscript
25 Jun 2022 Reviewed Reviewer Report
9 Dec 2022 Reviewed Reviewer Report
14 Dec 2022 Reviewed Reviewer Report
13 Jan 2023 Author responded Author comments - Weixin Zhao
Resubmission - Version 2
13 Jan 2023 Submitted Manuscript version 2
18 Jan 2023 Reviewed Reviewer Report
19 Jan 2023 Reviewed Reviewer Report
31 Jan 2023 Author responded Author comments - Weixin Zhao
Resubmission - Version 3
31 Jan 2023 Submitted Manuscript version 3
Publishing
2 Feb 2023 Editorially accepted
24 Feb 2023 Article published 10.1186/s12916-023-02768-z

You can find further information about peer review here.

Back to article page